Mark A. BehlkeBS, MD, PhD
Dr. Mark Behlke, M.D, Ph.D. serves as Chief Scientific Officer of Integrated DNA Technologies, Inc. Dr. Behlke co-founded Dicerna Pharmaceuticals, Inc. Dr. Behlke served as Vice President of Molecular Genetics & Biophysics for Integrated DNA Technologies since 1996. He serves as a Member of Scientific Advisory Board of Dicerna Pharmaceuticals, Inc.
Before joining IDT, Dr. Behlke was a Physician Postdoctoral Fellow of the Howard Hughes Medical Institute at the Whitehead Institute for Biomedical Research, MIT, where he studied human sex determination in the laboratory of Dr. David Page. He was a Resident Physician in Internal Medicine and Fellow in Endocrinology at Brigham and Women’s Hospital, Boston.
Dr. Behlke received his M.D. and Ph.D. degrees from Washington University, St. Louis in 1988, where he studied immunogenetics in the laboratory of Dr. Dennis Loh. He received his B.S. degree from the Massachusetts Institute of Technology in 1981.